Sesquiterpenoids from Chloranthus spicatus （Thunb.） Makino

Two new sesquiterpenoids, namely 1β,4β-dihydroxy-5 α,8β（H）-eudesm-7（11）Z-en-8,12-olide （1） and 1β,4α-dihydroxy-5α,8β（H）-eudesm-7（11）Z-en-8,12-olide （2）, along with six known ones, homalomenol A （3）, oplodiol （4）, 5α,7α（H）-6,8-cycloeudesma-1β,4β-diol （5）, oplopanone （6）, 4β,10α-dihydroxyaromadendrane （7） and spathulenol （8）, were isolated from the aerial part of Chloranthus spicatus （Thunb.） Makino, and their structures were established by spectroscopic methods.     

二氧化碳促进的醛和酮等羰基化合物烯丙基化反应研究

加入二氧化碳可以促进羰基化合物的烯丙基化反应. 实验结果表明: 在1.0 MPa的二氧化碳和2 equiv.的锡存在下, 以THF/H₂O为反应介质, 芳香醛化合物与烯丙基溴可以顺利地发生烯丙基化反应得到较高的产率, 而芳香酮化合物和脂肪醛等与烯丙基溴反应只得到较低的产率.     

Synthesis and properties of the copper(Ⅱ) complexes with stable radical

Four novel copper(Ⅱ) complexes have been synthesized,namely Cu(hfac)2NITPhNO2 (1),Cu(hfac)2NITPhCH3 (2),Cu(pfpr)2NITPhNO2,(3) and Cu(Pfpr)2NITPhCH3 (4),where hfac= hexafluoro-acetylacetonate,pfpr=pentafluoropropionate,NITR.=2-R-4,4,5,5-tetraniethyl-4,5-dihydro-1H-imidazolyl-1-oxyl-3-oxide.(R=4-nitrophenyl,4-methylphenyl).These complexes were rharicter-ized by elemental analyses,IR,electronic spectra and molar conductance.The temperature-dependent magnetic susceptibility of complexes 1 and 3 have been studied in the 4 300 K range,giving I he exchange integral J=10.56 cm-1 for complex 1 and J =-30.9 cm-1 for complex 3.     

Storage-Reduction of NOx over Combined Catalysts of Pt/Ba/Al2O3-Mn/Ba/Al2O3： Carbon Monoxide as Reductant

Storage-reduction of NOx by carbon monoxide was investigated over combined catalysts of Mn/Ba/Al2O3-Pt/Ba/Al2O3. Combination of Mn/Ba/Al2O3 and Pt/Ba/Al2O3 catalysts in different ways showed excellent NOx storage-reduction performance and the content of Pt could be reduced by 50%. Not only the addition of 5Mn/15Ba/Al2O3 to lPt/15Ba/Al2O3 could improve its storage ability, but also enhance the NOx conversion consequently. NOx conversion over the combined catalysts (the combined catalysts I and II) was increased under dynamic lean-rich burn conditions, the maximum NOx conversion increased from 69.4% to respectively 78.8% and 75.7% over two combined catalysts.     

负载型Au-Pd双金属催化剂的制备及其对CO氧化的催化活性

采用改性的等体积浸渍法制备了SiO2负载的Au-Pd双金属催化剂,考察了催化剂的焙烧温度对CO氧化反应活性的影响.与623,723和773K的条件下焙烧的催化剂相比,673K焙烧的催化剂具有良好的催化CO氧化活性,CO完全转化温度低于398K.应用N2物理吸附、X射线衍射、程序升温还原、CO程序升温脱附及X射线光电子能谱等技术对催化剂进行了表征.结果表明,673K焙烧的催化剂具有最大的比表面积和最小的孔径,存在Au0,Pd0和PdO相,AuxPdy合金相很少;而773K焙烧的催化剂上除了含有Au0,Pd0和PdO相外,还存在明显的AuxPdy合金相.具有大比表面积,小孔径,Au0,Pd0和PdO多相共存的催化剂可使CO的吸附量增加,催化活性提高;而AuxPdy合金相的生成并不能提高催化剂的催化活性.     

氧化-还原低温引发甲基丙烯酸甲酯/丙烯酸丁酯超浓乳液聚合研究

以乳化剂十二烷基硫酸钠 (SDS)和共乳化剂十六烷醇 (HD)作为复合乳化体系 ,过氧化二苯甲酰(BPO)和N ,N 二甲基苯胺 (DMA)作为氧化还原引发体系 ,甲基丙烯酸甲酯 丙烯酸丁酯 (MMA BA)作为混合单体 ,制备了分散相占 83 %以上的稳定的超浓乳液 ,然后在低温下引发聚合 .探讨了引发剂浓度、氧化剂与还原剂的摩尔比、乳化剂的浓度、液膜增强剂的种类、聚合温度等因素对聚合稳定性和聚合速率的影响 ,测定并计算得到了聚合速率的公式 ;用激光散射粒度分布仪测定了聚合物乳胶粒子的大小及粒径分布 ,用透射电子显微镜观察了聚合物乳胶粒的形态 ,讨论了乳化剂浓度、聚合温度等对乳胶粒形态、大小的影响     

以对-(4-烯丙氧基苯甲酰氧基)苯甲酸对-甲氧基苯酚酯为单体的液晶聚硅氧烷的合成与表征

侧链型液晶聚合物是目前很有兴趣的研究课题之一。在国内,有关的研究报道也逐渐增多,本工作设计并合成了对-(4-烯丙氧基苯甲酰氧基)苯甲酸对-甲氧基苯酚酯单体,其结构式为:     

Preparative SEC column packed with microporous particles prepared from cellulose

New microporous particles with large pore size (mean pore diameter of 820 nm) are successfully prepared from a mixture of cellulose and konjac glucomannan (RC-KGM3) in 1.5 M NaOH-0.65 M thiourea aqueous solution by coagulating with 5 weight percentage (wt%) CaCl(2), and then 2 wt% HCl aqueous solution. A preparative size-exclusion chromatographic (SEC) column packed with the gel particles is used for the fractionation of a dextran in water. The exclusion limit and fractionation range of the stationary phase are molecular masses of 125 yen 104 g/mol and 5.6 yen 104 to 125 yen 104 g/mol, respectively. The dextran [dextran 50, weight-average molecular mass (M(w)) = 40.1 yen 104 g/mol, polydispersity index (d) = 3.5] is fractionated by the preparative SEC column to obtain six fractions, and four of them are refractionated twice by the same preparative SEC column. The refractionated samples F-3-3 and F-4-3 are characterized by analytical SEC combined with laser light scattering and light scattering to obtain M(w) of 91.8 and 61.9 yen 104 g/mol, as well as d of 1.3 and 1.4, respectively. The results indicate that the fractions having narrow molecular mass distribution are satisfactorily prepared with the SEC column. The described SEC column can be successfully used to fractionate polymers in aqueous solution.     

Extraction Kinetics of Rare Earth Elements with sec—Octyl—phenoxy Acetic Acid

ＩｎｔｒｏｄｕｃｔｉｏｎＩｔｉｓｗｅｌｌｋｎｏｗｎｔｈａｔｙｔｔｒｉｕｍｃａｎｂｅｕｓｅｄｉｎｍａｎｙｆｉｅｌｄｓ ,ｓｕｃｈａｓｍｅｔａｌｌｕｒｇｙ ,ｃｅｒａｍｉｃｓ ,ｌａｓｅｒｓａｎｄｅｌｅｃｔｒｏｎ ｉｃｓ ,ｅｓｐｅｃｉａｌｌｙｉｎｆｌｕｏｒｅｓｃｅｎｔｍａｔｅｒｉａｌｓｗｈｏｓｅｎｅｅｄｆｏｒｈｉｇｈｐｕｒｉｔｙｙｔｔｒｉｕｍｏｘｉｄｅｉｓｉｎｃｒｅａｓｉｎｇ .ＩｎＣｈｉｎａ ,ｔｈｅｒｅ ｓｏｕｒｃｅｏｆｙｔｔｒｉｕｍｉｓｒｉｃｈ ,ａｎｄｔｈｅｈｉｇｈｐｕｒｅｙｔｔｒｉｕｍｉｓｂｅ ｉｎｇｏ…     

Mass spectrometry-based chemical mapping and profiling toward molecular understanding of diseases in precision medicine

Precision medicine has been strongly promoted in recent years. It is used in clinical management for classifying diseases at the molecular level and for selecting the most appropriate drugs or treatments to maximize efficacy and minimize adverse effects. In precision medicine, an in-depth molecular understanding of diseases is of great importance. Therefore, in the last few years, much attention has been given to translating data generated at the molecular level into clinically relevant information. However, current developments in this field lack orderly implementation. For example, high-quality chemical research is not well integrated into clinical practice, especially in the early phase, leading to a lack of understanding in the clinic of the chemistry underlying diseases. In recent years, mass spectrometry (MS) has enabled significant innovations and advances in chemical research. As reported, this technique has shown promise in chemical mapping and profiling for answering “what”, “where”, “how many” and “whose” chemicals underlie the clinical phenotypes, which are assessed by biochemical profiling, MS imaging, molecular targeting and probing, biomarker grading disease classification, etc. These features can potentially enhance the precision of disease diagnosis, monitoring and treatment and thus further transform medicine. For instance, comprehensive MS-based biochemical profiling of ovarian tumors was performed, and the results revealed a number of molecular insights into the pathways and processes that drive ovarian cancer biology and the ways that these pathways are altered in correspondence with clinical phenotypes. Another study demonstrated that quantitative biomarker mapping can be predictive of responses to immunotherapy and of survival in the supposedly homogeneous group of breast cancer patients, allowing for stratification of patients. In this context, our article attempts to provide an overview of MS-based chemical mapping and profiling, and a perspective on their clinical utility to improve the molecular understanding of diseases for advancing precision medicine.

An overview of MS-based chemical mapping and profiling, indicating its contributions to the molecular understanding of diseases in precision medicine by answering "what", "where", "how many" and "whose” chemicals underlying clinical phenotypes.